Zepp Health Corporation Sponsored ADR

ZEPP Technology Consumer Electronics

Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024.

Revenue
+6.93%
EPS
−46.9%
Free cash flow
−103.7%
Total debt
+26.4%

Quarter to June 2026, against a year earlier

2.34 0.12 +5.41%
Market cap
$18.8M
P/E
0.0×
Fwd P/E
−22.0×
Dividend yield
—
F-score
5/9
Altman Z
1.01
Beneish M
−2.49
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
— — 5 —

+8 more TTM periods

ROE
(21.23%) (18.76%) (17.15%) (24.35%)
ROA
(7.86%) (7.60%) (7.33%) (11.23%)
ROIC
(10.25%) (8.18%) (8.43%) (9.25%)
Return on Tangible Assets
164.91% 135.69% (324.62%) (208.31%)
Average Days of Receivables
109.21 83.77 103.73 136.43
Free Cash Flow per Share
0.00 0.00 (0.74) 0.00
Free Cash Flow
— — (11.76) —
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026